Arbutus Biopharma (ABUS)
(Delayed Data from NSDQ)
$3.87 USD
-0.09 (-2.27%)
Updated Nov 4, 2024 04:00 PM ET
After-Market: $3.86 -0.01 (-0.26%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO11/6/24 |
---|---|
Current Quarter | -0.10 |
EPS Last Quarter | -0.11 |
Last EPS Surprise | -10.00% |
ABR | 1.40 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.38 |
Next Year | -0.34 |
EPS (TTM) | -0.45 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.74M | 1.76M | 7.35M | 6.86M |
# of Estimates | 2 | 2 | 3 | 3 |
High Estimate | 1.77M | 1.82M | 8.50M | 7.78M |
Low Estimate | 1.70M | 1.70M | 6.70M | 5.90M |
Year ago Sales | 4.66M | 2.15M | 18.14M | 7.35M |
Year over Year Growth Est. | -62.77% | -18.14% | -59.48% | -6.67% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.10 | -0.09 | -0.38 | -0.34 |
# of Estimates | 2 | 2 | 3 | 3 |
Most Recent Consensus | -0.08 | -0.10 | -0.37 | -0.36 |
High Estimate | -0.08 | -0.07 | -0.36 | -0.29 |
Low Estimate | -0.11 | -0.10 | -0.39 | -0.43 |
Year ago EPS | -0.12 | -0.12 | -0.44 | -0.38 |
Year over Year Growth Est. | 16.67% | 25.00% | 13.64% | 10.53% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.10 | -0.09 | -0.38 | -0.34 |
7 Days Ago | -0.10 | -0.09 | -0.38 | -0.34 |
30 Days Ago | -0.10 | -0.09 | -0.38 | -0.34 |
60 Days Ago | -0.10 | -0.09 | -0.38 | -0.34 |
90 Days Ago | -0.10 | -0.09 | -0.38 | -0.34 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.10 | -0.09 | -0.38 | -0.34 |
Zacks Consensus Estimate | -0.10 | -0.09 | -0.38 | -0.34 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.11 | -0.10 | -0.12 | -0.12 | NA |
Estimate | -0.10 | -0.10 | -0.12 | -0.12 | NA |
Difference | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
Surprise | -10.00% | 0.00% | 0.00% | 0.00% | -2.50% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more